Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MDT | Medtronic PLC | 1.14% | 88.77 | 0.6% | $434.09m | |
| TMO | Thermo Fisher Scientific Inc. | 2.38% | 271.67 | 1.0% | $433.69m | |
| ISRG | Intuitive Surgical, Inc. | 0.37% | 485.37 | 2.4% | $388.14m | |
| BDX | Becton, Dickinson and Company | 0.75% | 235.73 | 1.1% | $376.82m | |
| ABT | Abbott Laboratories | 0.32% | 76.27 | 0.8% | $367.42m | |
| ALGN | Align Technology, Inc. | -0.27% | 318.82 | 6.3% | $341.92m | |
| BSX | Boston Scientific Corporation | 0.11% | 37.74 | 1.1% | $309.81m | |
| ABMD | ABIOMED, Inc. | 1.97% | 265.48 | 3.3% | $261.70m | |
| SYK | Stryker Corporation | 0.25% | 185.92 | 1.3% | $211.06m | |
| BAX | Baxter International Inc. | 0.37% | 75.58 | 1.7% | $197.08m | |
| EW | Edwards Lifesciences Corporation | 0.38% | 172.65 | 1.2% | $193.00m | |
| WAT | Waters Corporation | 0.50% | 207.18 | 3.8% | $157.08m | |
| ZBH | Zimmer Biomet Holdings, Inc. | -0.83% | 115.15 | 1.7% | $144.43m | |
| DXCM | DexCom, Inc. | 0.14% | 118.75 | 8.3% | $130.28m | |
| IDXX | IDEXX Laboratories, Inc. | 0.42% | 250.38 | 3.7% | $124.02m |
Company Profile
Atossa Genetics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. The ForeCYTE Breast Health Test provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65. The ArgusCYTE Breast Health Test offers information to help inform breast cancer treatment options and to help monitor potential recurrence. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.